• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分泌型磷脂酶A2在肥大细胞花生四烯酸释放和类花生酸生物合成中起作用的证据。

Evidence that secretory phospholipase A2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells.

作者信息

Fonteh A N, Bass D A, Marshall L A, Seeds M, Samet J M, Chilton F H

机构信息

Department of Internal Medicine, Bowman Gray School of Medicine, Winston-Salem, NC 27157.

出版信息

J Immunol. 1994 Jun 1;152(11):5438-46.

PMID:8189063
Abstract

This study investigated the role of secretory PLA2 (sPLA2) in arachidonic acid (AA) release and lipid mediator generation in mouse bone marrow-derived mast cells. Initial studies indicated that mast cells contain multiple PLA2 activities and secreted PLA2 activity upon Ag stimulation. The secreted PLA2 activity is blocked by DTT and by a group II PLA2-neutralizing Ab. Mast cells incubated with groups I or II PLA2 selectively release polyunsaturated fatty acids, such as AA, into supernatant fluids. The bulk of AA released by sPLA2 is derived from phosphatidylethanolamine. The fatty acids released by extracellular PLA2 mimic those found in supernatant fluids after Ag stimulation of mast cells. Incubation of mast cells with PLA2 generates cyclooxygenase (CO) products but no 5-lipoxygenase (5-LO) products. Ag, but not PLA2, induces the translocation of 5-LO to cellular membranes and the formation of 5-LO products. The addition of sPLA2 to Ag-stimulated mast cells increases the synthesis of 5-LO products. Octadeuterated AA (2H8AA) added to the outside of cells to trace extracellular AA metabolism is rapidly converted to CO products. Addition of sPLA2, or Ag in combination with 2H8AA reduces the quantity of 2H8AA converted to deuterated CO products, when compared with adding 2H8AA alone. The reduction of deuterated CO products can be accounted for with increases in nondeuterated CO products. 2H8AA is only converted to 5-LO produces when mast cells are activated with Ag. The amount of 2H8AA converted to deuterated 5-LO products is reduced by the addition of PLA2 to Ag-stimulated cells. The competitive formation of deuterated and nondeuterated products observed when mast cells are incubated with 2H8AA, indicates that extracellular AA released by sPLA2 is used for both CO and 5-LO product formation. Taken together, these data reveal a role for sPLA2 in the release of AA and demonstrate that AA released by this mechanism is used for eicosanoid generation.

摘要

本研究调查了分泌型磷脂酶A2(sPLA2)在小鼠骨髓来源肥大细胞中花生四烯酸(AA)释放及脂质介质生成过程中的作用。初步研究表明,肥大细胞含有多种磷脂酶A2活性,且在抗原刺激后会分泌磷脂酶A2活性。分泌的磷脂酶A2活性可被二硫苏糖醇(DTT)和一种II型磷脂酶A2中和抗体所阻断。用I型或II型磷脂酶A2孵育肥大细胞可选择性地将多不饱和脂肪酸,如AA,释放到上清液中。sPLA2释放的大部分AA来源于磷脂酰乙醇胺。细胞外磷脂酶A2释放出的脂肪酸与肥大细胞经抗原刺激后的上清液中发现的脂肪酸相似。用磷脂酶A2孵育肥大细胞会生成环氧化酶(CO)产物,但不会生成5-脂氧合酶(5-LO)产物。抗原而非磷脂酶A2可诱导5-LO转位至细胞膜并形成5-LO产物。将sPLA2添加到经抗原刺激的肥大细胞中可增加5-LO产物的合成。添加到细胞外以追踪细胞外AA代谢的十八氘代AA(2H8AA)会迅速转化为CO产物。与单独添加2H8AA相比,添加sPLA2或抗原与2H8AA组合会减少转化为氘代CO产物的2H8AA量。氘代CO产物的减少可通过非氘代CO产物的增加来解释。只有当肥大细胞用抗原激活时,2H8AA才会转化为5-LO产物。向经抗原刺激的细胞中添加磷脂酶A2会减少转化为氘代5-LO产物的2H8AA量。当肥大细胞与2H8AA孵育时观察到的氘代和非氘代产物的竞争性形成表明,sPLA2释放的细胞外AA可用于CO和5-LO产物的形成。综上所述,这些数据揭示了sPLA2在AA释放中的作用,并证明通过该机制释放的AA可用于类花生酸的生成。

相似文献

1
Evidence that secretory phospholipase A2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells.分泌型磷脂酶A2在肥大细胞花生四烯酸释放和类花生酸生物合成中起作用的证据。
J Immunol. 1994 Jun 1;152(11):5438-46.
2
Regulation of arachidonic acid, eicosanoid, and phospholipase A2 levels in murine mast cells by recombinant stem cell factor.重组干细胞因子对小鼠肥大细胞中花生四烯酸、类二十烷酸和磷脂酶A2水平的调节
J Clin Invest. 1995 Sep;96(3):1432-9. doi: 10.1172/JCI118179.
3
Mechanisms that account for the selective release of arachidonic acid from intact cells by secretory phospholipase A2.分泌型磷脂酶A2从完整细胞中选择性释放花生四烯酸的机制。
Biochim Biophys Acta. 1998 Aug 28;1393(2-3):253-66. doi: 10.1016/s0005-2760(98)00079-4.
4
Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells.分泌型磷脂酶A2受体介导的小鼠骨髓来源肥大细胞中胞质型磷脂酶A2的激活
J Immunol. 2000 Sep 1;165(5):2773-82. doi: 10.4049/jimmunol.165.5.2773.
5
Alterations in arachidonic acid metabolism in mouse mast cells induced to undergo maturation in vitro in response to stem cell factor.在干细胞因子作用下体外诱导成熟的小鼠肥大细胞中花生四烯酸代谢的改变。
J Allergy Clin Immunol. 1996 Jun;97(6):1329-41. doi: 10.1016/s0091-6749(96)70202-6.
6
Involvement of phospholipase A2 activation and arachidonic acid metabolism in the cytotoxic functions of rat NK cells.磷脂酶A2激活和花生四烯酸代谢在大鼠自然杀伤细胞细胞毒性功能中的作用。
Cell Immunol. 1993 May;148(2):247-58. doi: 10.1006/cimm.1993.1109.
7
Distinct phospholipases A2 regulate the release of arachidonic acid for eicosanoid production and superoxide anion generation in neutrophils.不同的磷脂酶A2调节中性粒细胞中花生四烯酸的释放,用于类花生酸的产生和超氧阴离子的生成。
J Immunol. 1998 Jan 15;160(2):953-60.
8
Induction of cyclooxygenase-2 by secretory phospholipases A2 in nerve growth factor-stimulated rat serosal mast cells is facilitated by interaction with fibroblasts and mediated by a mechanism independent of their enzymatic functions.在神经生长因子刺激的大鼠浆膜肥大细胞中,分泌型磷脂酶A2诱导环氧合酶-2的过程因与成纤维细胞的相互作用而得到促进,且由一种独立于其酶功能的机制介导。
J Immunol. 1998 Nov 1;161(9):5008-15.
9
The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2.五种不同的哺乳动物磷脂酶A2在调节花生四烯酸释放中的功能。IIa型和V型分泌性磷脂酶A2在功能上是冗余的,并与胞质磷脂酶A2协同作用。
J Biol Chem. 1998 Jun 5;273(23):14411-23. doi: 10.1074/jbc.273.23.14411.
10
Induction of interleukin-6 release by interleukin-1 in rat anterior pituitary cells in vitro: evidence for an eicosanoid-dependent mechanism.白细胞介素-1体外诱导大鼠垂体前叶细胞释放白细胞介素-6:类花生酸依赖机制的证据
Endocrinology. 1991 Dec;129(6):2886-94. doi: 10.1210/endo-129-6-2886.

引用本文的文献

1
Review of Eukaryote Cellular Membrane Lipid Composition, with Special Attention to the Fatty Acids.真核生物细胞膜脂质组成综述,特别关注脂肪酸。
Int J Mol Sci. 2023 Oct 28;24(21):15693. doi: 10.3390/ijms242115693.
2
Metabolic Dynamics of In Vitro CD8+ T Cell Activation.体外CD8 + T细胞活化的代谢动力学
Metabolites. 2020 Dec 28;11(1):12. doi: 10.3390/metabo11010012.
3
The Biosynthesis of Enzymatically Oxidized Lipids.酶氧化脂质的生物合成。
Front Endocrinol (Lausanne). 2020 Nov 19;11:591819. doi: 10.3389/fendo.2020.591819. eCollection 2020.
4
Effect of bee venom or proplis on molecular and parasitological aspects of Schistosoma mansoni infected mice.蜂毒或蜂胶对曼氏血吸虫感染小鼠的分子及寄生虫学方面的影响。
J Parasit Dis. 2016 Jun;40(2):390-400. doi: 10.1007/s12639-014-0516-5. Epub 2014 Aug 31.
5
Secreted phospholipase A2 is increased in meconium-stained amniotic fluid of term gestations: potential implications for the genesis of meconium aspiration syndrome.足月妊娠胎粪污染羊水中分泌型磷脂酶A2增加:对胎粪吸入综合征发病机制的潜在影响。
J Matern Fetal Neonatal Med. 2014 Jul;27(10):975-83. doi: 10.3109/14767058.2013.847918. Epub 2014 Jan 6.
6
Mast cells: from lipid droplets to lipid mediators.肥大细胞:从脂滴到脂类介质。
Clin Sci (Lond). 2013 Aug;125(3):121-30. doi: 10.1042/CS20120602.
7
Effect of Extremely Low Frequency Electromagnetic Fields (EMF) on Phospholipase Activity in the Cultured Cells.极低频电磁场(EMF)对培养细胞中磷脂酶活性的影响。
Korean J Physiol Pharmacol. 2010 Dec;14(6):427-33. doi: 10.4196/kjpp.2010.14.6.427. Epub 2010 Dec 31.
8
Morinda citrifolia Inhibits Both Cytosolic Ca-dependent Phospholipase A(2) and Secretory Ca-dependent Phospholipase A(2).诺丽果抑制细胞质 Ca 依赖性磷脂酶 A(2)和分泌 Ca 依赖性磷脂酶 A(2)。
Korean J Physiol Pharmacol. 2010 Jun;14(3):163-7. doi: 10.4196/kjpp.2010.14.3.163. Epub 2010 Jun 30.
9
Lung mast cells are a source of secreted phospholipases A2.肺肥大细胞是分泌型磷脂酶A2的一个来源。
J Allergy Clin Immunol. 2009 Sep;124(3):558-65, 565.e1-3. doi: 10.1016/j.jaci.2009.04.035. Epub 2009 Jul 9.
10
The secretory phospholipase A2 group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis?分泌型磷脂酶A2 IIA组:炎症、激活的肾素-血管紧张素系统与动脉粥样硬化之间缺失的环节?
Vasc Health Risk Manag. 2008;4(3):597-604. doi: 10.2147/vhrm.s2008.